Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction

Medicine and Dentistry

• Antibody 10%
• Autophosphorylation 10%
• Bioavailability 20%
• Cardiovascular Disease 10%
• Casein Kinase II 10%
• Cells 20%
• Cord Blood 10%
• Diabetes 10%
• Enzymatic Assay 10%
• Enzyme Linked Immunosorbent Assay 20%
• Fetus 30%
• Fetus Growth 100%
• Gestational Age 10%
• Growth 30%
• Hepatocyte 20%
• Human 10%
• Hyperphosphorylation 30%
• Infant 10%
• Life 10%
• Liver 50%
• Mechanistic Target of Rapamycin 60%
• Newborn Disease 10%
• Nutrient 20%
• Pathophysiology 10%
• Phosphorylation 60%
• Plasma 10%
• Receptor 10%
• Regulatory Mechanism 20%
• Therapeutic Procedure 10%
• Western Blot 40%

Biochemistry, Genetics and Molecular Biology

• Age 10%
• Antibody 10%
• Autophosphorylation 10%
• Baboon 60%
• Fetus Growth 100%
• Growth 30%
• Hepatocyte 20%
• Human 10%
• Hyperphosphorylation 30%
• Life 10%
• Mammalian Target of Rapamycin 60%
• Phosphorylation 60%
• Protein Kinase 10%
• Regulatory Mechanism 20%